the risk for the pandemic transmission and spread in China remains.Currently,the administration of COVID-19 vaccines is carried out systematically worldwide,with novel coronavirus(2019-nCov)-specific antibodies
If you survive the virus once and develop antibodies to it that will be very good, but if the virus mutates extensively, there is a chance that those antibodies may not be effective against the new strain similarly to vaccines for the flu, which sometimes work against the new strain and ...
clinical observation, and deliberations among more than a dozen world-leading physicians and medical scientists, the FLCCC has released its protocol to treat those suffering from side effects from the COVID-19 vaccines, a condition identified as “Post-Vaccine S...
Currently, the Moderna, Pfizer BioNTech COVID-19, and Novovax vaccines are authorized by the US Food and Drug Administration (FDA) for use in children in ages 6 months and older, which includes 2- and 3-dose series for some age groups and vaccine formulations [10]. Severe acute respirator...
The rising fear in Europe and North America that visitors from China will carry some new variants or sub-variants of the virus and spread it in those regions is nothing but speculation, and bad speculation at that. Also, many claim that the Chinese COVID-19 vaccines are not as effective ...
New vaccines that are initially approved in clinical trials are not completely free of risks. Systematic vaccine safety surveillance is required for ensuring safety of vaccines. This study aimed to provide a protocol for safety monitoring of COVID-19 vac
The rising fear in Europe and North America that visitors from China will carry some new variants or sub-variants of the virus and spread it in those regions is nothing but speculation, and bad speculation at that. Also, many claim that the Chinese COVID-19 vaccines are not as effective ...
The COVID-19 pandemic is now in its second year. The discovery of effective vaccines has been a very anticipated and welcome development. Some therapies have been found to improve outcomes including corticosteroids [40,41], the IL-6 receptor antagonists, tocilizumab and sarilumab [42,43], and...
An ionizable lipid toolbox for RNA delivery. Nat Commun. 2021 Dec 13;12(1):7233. doi: 10.1038/s41467-021-27493-0.[3] Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, Crommelin DJA. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability. Int J...
Influenza vaccines are estimated to have protective effects by generating antibodies within 30 days post-vaccination, so events occurring within 30 days after discharge are considered unlikely to be preventable by influenza vaccination. Thus, events that occur in that occur in the non-influenza season...